We are live on ! Find out more
WRM

Weybosset Research & Management Portfolio holdings

AUM $347M
1-Year Est. Return 29.87%
This Fund
S&P 500
This Quarter Est. Return
-12.98%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
-$27M
Cap. Flow
-$3.28M
Cap. Flow %
-2.24%
Top 10 Hldgs %
53.68%
Holding
57
New
2
Increased
16
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$413K
2
WELL icon
Welltower
WELL
+$197K
3
COF icon
Capital One
COF
+$71.9K
4
FMC icon
FMC
FMC
+$67.7K
5
NOK icon
Nokia
NOK
+$63.8K

Top Sells

Rank Stock Value
1
INGR icon
Ingredion
INGR
+$930K
2
PII icon
Polaris
PII
+$492K
3
APTV icon
Aptiv
APTV
+$421K
4
SLB icon
SLB Ltd
SLB
+$332K
5
AMZN icon
Amazon
AMZN
+$224K

Sector Composition

Rank Sector Weight
1 Industrials 31.77%
2 Financials 15.79%
3 Technology 12.42%
4 Healthcare 11.06%
5 Consumer Discretionary 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
1
Copart
CPRT
$25.9B
$12.3M 8.4%
1,030,320
-2,192
-0.2% -$27.1K
DE icon
2
Deere & Co
DE
$170B
$9.05M 6.18%
60,702
-70
-0.1% -$10.3K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.07T
$8.82M 6.02%
43,207
-61
-0.1% -$12.7K
KEYS icon
4
Keysight
KEYS
$54.5B
$7.67M 5.24%
123,576
+355
+0.3% +$21.4K
JNJ icon
5
Johnson & Johnson
JNJ
$635B
$7.64M 5.21%
59,190
-955
-2% -$133K
AGM icon
6
Federal Agricultural Mortgage
AGM
$2.27B
$7.2M 4.92%
119,191
+765
+0.6% +$50.8K
TJX icon
7
TJX Companies
TJX
$170B
$6.74M 4.6%
150,747
-755
-0.5% -$38.1K
FMC icon
8
FMC
FMC
$1.42B
$6.45M 4.4%
100,591
+965
+1% +$67.7K
CNI icon
9
Canadian National Railway
CNI
$78.3B
$6.43M 4.39%
86,712
+28
+0% +$2.32K
GD icon
10
General Dynamics
GD
$105B
$6.32M 4.31%
40,182
+58
+0.1% +$10.4K
INGR icon
11
Ingredion
INGR
$6.38B
$6.23M 4.25%
68,113
-9,290
-12% -$930K
HPQ icon
12
HP
HPQ
$23.5B
$6.08M 4.15%
297,351
+550
+0.2% +$12.8K
COF icon
13
Capital One
COF
$124B
$5.4M 3.69%
71,476
+830
+1% +$71.9K
CMI icon
14
Cummins
CMI
$91.7B
$5.37M 3.67%
40,182
+246
+0.6% +$34.7K
APTV icon
15
Aptiv
APTV
$12B
$4.52M 3.09%
73,473
-5,815
-7% -$421K
NYT icon
16
New York Times
NYT
$11.6B
$4.51M 3.08%
202,535
-680
-0.3% -$17.2K
MIDD icon
17
Middleby
MIDD
$6.05B
$4.51M 3.08%
43,897
+76
+0.2% +$8.65K
CL icon
18
Colgate-Palmolive
CL
$72.6B
$4.03M 2.75%
67,703
-45
-0.1% -$2.81K
LH icon
19
Labcorp
LH
$24.3B
$3.56M 2.43%
32,791
+294
+0.9% +$39.4K
DGX icon
20
Quest Diagnostics
DGX
$25.1B
$3.37M 2.3%
40,442
-527
-1% -$49.4K
TCP
21
DELISTED
TC Pipelines LP
TCP
$2.89M 1.97%
89,998
-3,995
-4% -$122K
PII icon
22
Polaris
PII
$4.15B
$2.74M 1.87%
35,715
-5,470
-13% -$492K
JKHY icon
23
Jack Henry & Associates
JKHY
$10.7B
$2.6M 1.78%
20,571
-228
-1% -$32.4K
XOM icon
24
ExxonMobil
XOM
$651B
$1.6M 1.09%
23,501
-299
-1% -$23.5K
KO icon
25
Coca-Cola
KO
$354B
$702K 0.48%
14,829
-549
-4% -$26.3K

Similar funds

Weybosset Research & Management's Q4 2018 Portfolio in Review

As of Q4 2018, Weybosset Research & Management held 57 positions worth $147M, down 16% from $174M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Weybosset Research & Management's Q4 2018 filing shows 2 new, 16 increased, 29 reduced and 5 closed positions. Its largest new stake was AbbVie: 4,700 shares worth $433K. The largest sale was Ingredion, an estimated $930K.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, up from 31% a quarter earlier, followed by Financials and Technology.

  • Weybosset Research & Management's largest Q4 2018 buy was AbbVie: 4,700 shares worth $433K.
  • Weybosset Research & Management added most to Welltower in Q4 2018, an estimated $197K increase.
  • Weybosset Research & Management's biggest Q4 2018 reduction was Ingredion, cutting an estimated $930K.
  • Weybosset Research & Management fully exited SLB Ltd in Q4 2018, selling an estimated $332K.
  • Weybosset Research & Management's ten largest holdings make up 54% of its $147M portfolio in Q4 2018.
  • Weybosset Research & Management opened 2 new positions and closed 5 in Q4 2018.
  • Weybosset Research & Management's portfolio value fell 16% quarter-over-quarter to $147M.

Based on Weybosset Research & Management's 13F filing for Q4 2018, filed 25 Jan 2019.